Oxiracetam

SKU: orb1309676

Description

Oxiracetam (ISF-2522) is a nootropic compound and a cyclic GABA derivative used in research for cognitive enhancement. Studies in animal models and cellular systems investigate its potential to ameliorate memory deficits and support neurochemical function in cognitive disorders.

Research Area

Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 62613-82-5
• MW: 158.16
• Purity: 99.69%
• Formula: C₆H₁₀N₂O₃
• SMILES: C(C(N)=O)N1CC(O)CC1=O
• Target: GABA Receptor,NO Synthase
• Solubility: DMSO:10 mg/mL (63.23 mM)

Bioactivity

• In Vitro:
  In BALB/c mice, Oxiracetam (50 mg/kg i.p.) has been shown to improve avoidance acquisition. Similarly, in rats, pretreatment with Oxiracetam (30 mg/kg) has demonstrated efficacy in ameliorating cognitive deficits induced by trimethyltin.

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

ISF-2522, ISF 2522, ISF2522, inhibit, Inhibitor, Gamma-aminobutyric acid Receptor, GABAReceptor, GABAR, GABA Receptor, γ-Aminobutyric acid Receptor, Oxiracetam

Compound Identifiers

PubChem CID

4626